Company news
Cytophage Technologies Ltd. (TSXV:CYTO) news
Cytophage Technologies Ltd. news releases on 6ix. Latest, May 22, 2026: Cytophage Announces Filings Under the BIA
Press releases & updates
Cytophage Announces Filings Under the BIA
May 22, 2026
Cytophage Announces Resignation of Director
May 1, 2026
Cytophage Announces Departure of Chief Operating Officer
April 14, 2026
Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives
March 6, 2026
Canadian Investment Regulatory Organization Trade Resumption - CYTO
February 19, 2026
Canadian Investment Regulatory Organization Trading Halt - CYTO
February 19, 2026
Cytophage Announces Operational Restructuring
February 19, 2026
Cytophage Announces Appointment of James Kinley as Chief Financial Officer
January 20, 2026
Cytophage Announces Closing of Non-Brokered Private Placement and Filing of Q3 Financials
November 28, 2025
Cytophage Announces Closing of First Tranche of Non-Brokered Private Placement
November 12, 2025
Cytophage Announces Closing Date of its Non-Brokered Private Placement
November 5, 2025
Cytophage Announces Non-Brokered Private Placement
October 17, 2025
Cytophage Announces the Commercialization of OvaPhage in Canada Through W.L.T. Distributors Inc.
October 16, 2025
Cytophage Receives Federal Support for Entry into European Market through France Biomanufacturing Mission
September 29, 2025
Cytophage Reports Successful Results and Data from Second EU Pilot Study for AviPhage
September 23, 2025
Cytophage Identifies Two New Patient Candidates for Phage Therapy for Prosthetic Joint Infections
September 11, 2025
Cytophage Secures Health Canada Validation for OvaPhage and PhageFend Products for use in Food Safety
August 25, 2025
Cytophage Welcomes New Chairman Thomas Wellner and Announces Grant of Options and RSUs
August 1, 2025
Cytophage Technologies Reports Successful E. Coli Containment in EU Pilot Study for AviPhage
July 28, 2025
Cytophage Announces Closing of Upsized Non-Brokered Private Placement
June 10, 2025
Cytophage Announces Mailing of Annual and Special Meeting Materials with Board Nominees
June 3, 2025
Cytophage Announces Upsizing of its Non-Brokered Private Placement
May 29, 2025
Cytophage Technologies Ltd. Secures Government of Canada New Substance Notification Approval to Facilitate Enterococcus Phage Therapy Trials
May 8, 2025
Cytophage Enters European Poultry Market with Start of AviPhage Pilot Study
April 30, 2025
Cytophage Announces Development of New Phage-Based H5N1 Vaccine and Advancement Toward Preclinical Trials
February 27, 2025
Cytophage Named Bioscience Company of the Year by Bioscience Association Manitoba
February 20, 2025
Cytophage Launches Incubator Egg Trials for OvaPhage in Partnership with Leading Canadian Hatchery
February 5, 2025
VIDEO ENHANCED Cytophage Technologies Reports Positive Outcome from Innovative Bacteriophage Therapy in Patient with Antibiotic-Resistant Infection
December 17, 2024
New Partnership Between Cytophage, Orthopedic Innovation Centre Targets Prosthetic Joint Infections Using Phage Therapy
December 12, 2024
Cytophage Celebrates Opening of State-of-the-Art Phage Production Facility in Winnipeg
December 5, 2024
Cytophage Reports Q3 2024 Financials and Business Update
November 27, 2024
Cytophage Highlights Existing Phage Solutions to Recent Harmful Bacteria Outbreaks in Food Systems
November 11, 2024
Cytophage CEO to Discuss Reshaping Healthcare Through Phage Therapies During 2024 Canada SynBio Conference
October 4, 2024
Cytophage Reports Q2 Financials including Business Update for First Half of 2024
August 28, 2024
Cytophage Launches Ready-to-Use Lyophilized Phage Tablets to Improve Gut Health in Poultry
August 15, 2024
Cytophage Reports AGM Results and Announces Upcoming Investor Call
June 27, 2024
Cytophage Expands Commercialization of Phage Products in Asian Poultry Market
June 20, 2024
Cytophage CEO to Present at TEDx Winnipeg Event
June 4, 2024
Cytophage Reports Q1 Financials and Provides Business Update
May 30, 2024
Cytophage Strengthens Board of Directors
May 27, 2024
Cytophage Announces Fiscal Year End 2023 Results
April 30, 2024
Cytophage Appoints New Board Director
April 16, 2024
Cytophage Provides Update on Bacteriophage Human Trial at The Ottawa Hospital
April 2, 2024
Cytophage Provides Bacteriophages for Landmark Treatment of Joint Replacement Infection in Canada
March 1, 2024
Cytophage Update on Upcoming Product for Egg Production in Canada
February 12, 2024